Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

105.28 +1.22 (+1.17%)

Streaming Delayed Price Updated: 2:37 PM EDT, Mar 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

53 54 Next >

A Significant Reversal is in Sight for These 5 Med Tech Companies

August 30, 2023

Med tech stocks are down YOY despite strong secular tailwinds, cash flow, and dividends; the downturn in action is an opportunity and reversal is at hand.

Via MarketBeat

How Lawmakers Want To Stop Cronobacter Outbreaks That Spurred Baby Formula Shortage Last Year ↗

August 29, 2023

Under bipartisan Congressional legislation, baby formula manufacturers must notify the U.S.

Via Benzinga

5 Good Reasons it's Time to Buy High-Yield Dividend King 3M

August 29, 2023

3M settled the ear plug lawsuit, clearing the path forward. The stock offers investors a high yield and value that may be too hard to pass up

Via MarketBeat

Topics Lawsuit

1 Stock-Split Stock Billionaires Are Buying Hand Over Fist and 1 Unexpected Stock-Split Stock They're Selling ↗

August 28, 2023

Some of the world's most successful investors are focusing on stocks.

Via The Motley Fool

This Is What Whales Are Betting On Abbott Laboratories ↗

August 21, 2023

Via Benzinga

2 Blue Chip Dividend Stocks That Are Top Buys in August ↗

August 14, 2023

These two dividend-paying healthcare stocks stand out as top buys right now.

Via The Motley Fool

How Is The Market Feeling About Abbott Laboratories? ↗

August 10, 2023

Via Benzinga

U.S. Credit Rating Concerns? Here Are 3 Stocks to Protect Your Portfolio ↗

August 24, 2023

Looking for stocks to buy amid the U.S. credit rating downgrade? Look no further. These companies have you covered.

Via InvestorPlace

Want Growing Passive Income? This Dividend King Could Be a Smart Buy ↗

August 23, 2023

The company boasts one of the longest dividend growth streaks in the healthcare sector.

Via The Motley Fool

2 Healthcare Stocks You Can Buy and Hold for the Next Decade ↗

August 19, 2023

Investors can expect steady returns from these two longtime market-beaters.

Via The Motley Fool

Down 4% to 17%, These Monster Dividend Stocks Could Be Picking Up Steam ↗

August 19, 2023

These companies have shown they can increase their lucrative dividends regardless of company struggles in recent times.

Via The Motley Fool

Trillion-Dollar Trio: These 3 Super Growth Stocks Will Dominate the Market by 2035 ↗

August 17, 2023

As companies naturally continue to expand and the stock market grows, trillion-dollar valuations will be a more common occurrence.

Via InvestorPlace

Is Abbott Laboratories Stock a Buy Now? ↗

August 10, 2023

The healthcare company recently boosted its guidance.

Via The Motley Fool

This Is What Whales Are Betting On Abbott Laboratories ↗

August 04, 2023

Via Benzinga

Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years ↗

July 31, 2023

Via Benzinga

Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years ↗

August 16, 2023

Via Benzinga

2 Best Healthcare Stocks to Buy Right Now ↗

August 14, 2023

The healthcare sector has plenty of growth tailwinds.

Via The Motley Fool

Boston Scientific's Farapulse Eyes Stronger US Market Position With Potential FDA Approval ↗

August 11, 2023

Boston Scientific Corp (NYSE: BSX) will present results from ADVENT pivotal trial for its Farapulse Pulsed Field Ablation (PFA) system at the 2023 European Society of Cardiology Congress on 27 August....

Via Benzinga

Is AbbVie Still a Good Dividend Stock to Buy? ↗

August 08, 2023

Find out if AbbVie can overcome sinking sales of its top-selling product.

Via The Motley Fool

2 Top Stocks to Buy in August and Hold Forever ↗

August 06, 2023

These companies won't disappoint long-term investors.

Via The Motley Fool

Does Abbott Laboratories' Dividend Make It a Buy? ↗

August 04, 2023

There's a lot to like about this business when it comes to dividends.

Via The Motley Fool

Looking Into Abbott Laboratories's Recent Short Interest ↗

July 25, 2023

Via Benzinga

Glucose Monitor Maker DexCom In Buy Zone After Gapping Higher

July 31, 2023

Strong Q2 earnings performance propelled DexCom higher. Investors cheered the glucose monitoring leader's bullish sales view and international expansion plans.

Via MarketBeat

10 Health Care Stocks With Whale Alerts In Today's Session ↗

July 28, 2023

Via Benzinga

Dexcom Earnings Tops Estimates, Medical Device Maker Hikes Outlook ↗

July 27, 2023

Dexcom stock rose after the company reported Q2 earnings and revenue that topped Wall Street targets and raised full-year sales guidance.

Via Investor's Business Daily

Chronic Pain Specialist Speaks At Panel On Stem Cell-Based Therapies And The Need For Spinal Care Reform – Insights From The Discussion ↗

July 27, 2023

Chronic back pain is a significant issue in the United States, affecting millions of individuals annually.

Via Benzinga

Abbott Recalls Amplatzer Steerable Delivery Sheath On Risk Of Air Embolism ↗

July 26, 2023

Abbott Laboratories (NYSE: ABT) is recalling the Amplatzer Steerable Delivery Sheath due to an increased

Via Benzinga

2 Top Dividend Stocks to Buy and Hold Forever ↗

July 25, 2023

They have been paying dividends for a long time.

Via The Motley Fool

Russia Is Seizing European Company Assets — What US Businesses Are Still At Risk? ↗

July 24, 2023

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

July 24, 2023

Via Benzinga

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

53 54 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.